Prevention of conventional AD would be carried out in the context of the inoperative AβPP-independent iAβ generation pathway, and a single transient depletion of iAβ via the activation of BACE1 and/or BACE2 implemented in mid-life is apparently sufficient to prevent conventional AD and AACD for the remaining lifetime. The gene discussed is BACE2; the disease is Alzheimer disease.